US 9107912
Methods for concomitant treatment of theophylline and febuxostat
granted A61KA61K31/415A61K31/426
Quick answer
US patent 9107912 (Methods for concomitant treatment of theophylline and febuxostat) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceuticals U.S.A., Inc.
- Grant date
- Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/415, A61K31/426, A61K31/522, A61K45/06